Inhibition of peripheral aromatization of androstenedione to estrone in postmenopausal women with breast cancer using delta 1-testololactone

The Journal of Clinical Endocrinology and Metabolism
R M BaroneH L Judd

Abstract

To determine if delta 1-testololactone can inhibit the peripheral aromatization of androstenedione (delta), nine postmenopausal women with metastatic breast cancer were studied before and after 2 weeks of therapy with 250 mg of the drug, given every 6 h by mouth. The conversion ratio of delta to estrone (E1) was significantly reduced (P less than 0.005) from a mean (+/-SE) of 0.0098 +/- 0.0025 before to 0.0009 +/- 0.0005 after treatment. The drug's effect on the metabolism of delta seemed to be specific since significant changes in the MCR of delta and in the conversion ratio to testosterone were not observed. That this inhibition of peripheral aromatization had an effect on E1 metabolism was shown by the significant decrease (P less than 0.01) of mean serum E1 levels from 22 +/- 3 pg/ml before to 12 +/- 1 pg/ml after treatment. Serum estradiol levels rose slightly from 8 +/- 0.8 to 12 +/- 4 pg/ml. Serum delta and testosterone levels were unchanged by therapy. These data are consistent with the concept that delta 1-testololactone is a potent inhibitor of peripheral aromatization of delta to E1. This mechanism could explain the antitumor properties of this compound.

Citations

Jan 1, 1994·Breast Cancer Research and Treatment·G Cocconi
Jan 1, 1990·Cancer Chemotherapy and Pharmacology·P E Lønning
Apr 25, 2007·Journal of Cancer Research and Clinical Oncology·Gabriel WcisloCezary Szczylik
Nov 2, 2007·Medical Oncology·Udayan Dutta, Kartikeya Pant
Jan 29, 2008·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Jürgen Geisler
Nov 1, 1976·Journal of Steroid Biochemistry·P K SiiteriN K Takaki
Nov 1, 1986·Journal of Steroid Biochemistry·A M BrodieR C Coombes
Nov 1, 1986·Journal of Steroid Biochemistry·D HendersonM F el Etreby
Jan 1, 1987·Journal of Steroid Biochemistry·D Henderson
Jan 1, 1988·Pharmacology & Therapeutics·S P Robinson, V C Jordan
Jun 1, 1989·Cancer Treatment Reviews·W R Miller
Dec 10, 1990·The Journal of Steroid Biochemistry and Molecular Biology·S TagaK Sekiba
Dec 1, 1992·The Journal of Steroid Biochemistry and Molecular Biology·H Vanden Bossche
Aug 26, 1998·The Journal of Steroid Biochemistry and Molecular Biology·A M Brodie, V C Njar
Dec 23, 2003·Best Practice & Research. Clinical Endocrinology & Metabolism·W R Miller
Dec 23, 2003·Best Practice & Research. Clinical Endocrinology & Metabolism·Per Eystein Lønning
Feb 28, 2003·Expert Opinion on Investigational Drugs·W R Miller, J Jackson
Jul 16, 2008·Expert Opinion on Drug Metabolism & Toxicology·Per Eystein Lønning, Jürgen Geisler
Oct 30, 2009·Acta Oncologica·Per Eystein Lønning
Jan 1, 1990·Annals of the New York Academy of Sciences·E di SalleG Ornati
Mar 28, 2019·Chemical Biology & Drug Design·Antonio PeónPedro J Ballester
Jan 1, 1990·Acta Oncologica·P E Lønning
Nov 1, 1988·Journal of Endocrinological Investigation·F Sciarra
Jan 1, 1989·Seminars in Surgical Oncology·T L Dao
Apr 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jürgen Geisler, Per Eystein Lønning
Jun 27, 2002·Biochimica Et Biophysica Acta·Paolo Lombardi
Oct 21, 1999·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M N KulaylatJ L Ambrus
Apr 1, 1991·American Journal of Surgery·W R Waddell, W M Kirsch
May 1, 1997·Cancer Treatment Reviews·W R Miller
Jan 1, 1986·Critical Reviews in Oncology/hematology·A M Brodie, R J Santen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.